Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+8.52%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$42.7B
AUM Growth
-$2.16B
(-4.8%)
Cap. Flow
-$4.85B
Cap. Flow
% of AUM
-11.36%
Top 10 Holdings %
Top 10 Hldgs %
17.46%
Holding
2,600
New
186
Increased
692
Reduced
1,373
Closed
340
Top Buys
| 1 |
Bank of America
BAC
|
+$404M |
| 2 |
Broadcom
AVGO
|
+$346M |
| 3 |
Merck
MRK
|
+$296M |
| 4 |
Wells Fargo
WFC
|
+$296M |
| 5 |
Cisco
CSCO
|
+$278M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$618M |
| 2 |
Amazon
AMZN
|
+$558M |
| 3 |
PayPal
PYPL
|
+$392M |
| 4 |
Netflix
NFLX
|
+$383M |
| 5 |
Advanced Micro Devices
AMD
|
+$351M |
Sector Composition
| 1 | Technology | 25.99% |
| 2 | Healthcare | 15.31% |
| 3 | Financials | 14.97% |
| 4 | Consumer Discretionary | 11.06% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Identive
INVE
$90.1M
| $116K | ﹤0.01% |
32,800
-2,300
| -7% | -$8.12K |
|
2152
Vinci Compass Investments Ltd. Class A Common Shares
VINP
$636M
| $115K | ﹤0.01% |
11,600
-20,000
| -63% | -$199K |
|
2153
Provident Bancorp
PVBC
$229M
| $114K | ﹤0.01% |
10,600
-2,300
| -18% | -$24.8K |
|
2154
Xperi
XPER
$284M
| $113K | ﹤0.01% |
12,200
-4,900
| -29% | -$45.3K |
|
2155
Sana Biotechnology
SANA
$762M
| $112K | ﹤0.01% |
26,900
+7,800
| +41% | +$32.4K |
|
2156
Blue Foundry Bancorp
BLFY
$203M
| $110K | ﹤0.01% |
10,700
-3,900
| -27% | -$40K |
|
2157
MindMed
MNMD
$714M
| $110K | ﹤0.01% |
19,250
-65,767
| -77% | -$374K |
|
2158
Duluth Holdings
DLTH
$145M
| $109K | ﹤0.01% |
28,900
-1,100
| -4% | -$4.14K |
|
2159
Harvard Bioscience
HBIO
$20.2M
| $107K | ﹤0.01% |
39,956
-35,700
| -47% | -$96K |
|
2160
Rallybio
RLYB
$24.8M
| $107K | ﹤0.01% |
91,600
+67,100
| +274% | +$78.5K |
|
|
PSTX
2161
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $107K | ﹤0.01% |
+37,400
| New | +$107K |
|
|
NIU
2162
Niu Technologies
NIU
$336M
| $101K | ﹤0.01% |
+44,100
| New | +$101K |
|
2163
Ultralife
ULBI
$116M
| $101K | ﹤0.01% |
11,200
-19,400
| -63% | -$175K |
|
2164
Braskem
BAK
$1.43B
| $101K | ﹤0.01% |
+13,700
| New | +$101K |
|
2165
Arteris
AIP
$366M
| $99.6K | ﹤0.01% |
12,900
-21,700
| -63% | -$168K |
|
2166
Prelude Therapeutics
PRLD
$70.8M
| $99.2K | ﹤0.01% |
47,900
-3,000
| -6% | -$6.21K |
|
2167
Clarus
CLAR
$150M
| $98.8K | ﹤0.01% |
21,961
-4,500
| -17% | -$20.3K |
|
2168
1-800-Flowers.com
FLWS
$317M
| $97.5K | ﹤0.01% |
12,300
-9,700
| -44% | -$76.9K |
|
2169
Globalstar
GSAT
$4.68B
| $96.5K | ﹤0.01% |
5,187
-5,466
| -51% | -$102K |
|
2170
Tilly's
TLYS
$60.6M
| $94.4K | ﹤0.01% |
18,500
-16,200
| -47% | -$82.6K |
|
2171
DHI Group
DHX
$143M
| $93.5K | ﹤0.01% |
50,800
-27,100
| -35% | -$49.9K |
|
|
LGF.A
2172
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $92.4K | ﹤0.01% |
11,800
-29,900
| -72% | -$234K |
|
2173
ADC Therapeutics
ADCT
$396M
| $92.2K | ﹤0.01% |
29,276
-6,800
| -19% | -$21.4K |
|
2174
Precigen
PGEN
$1.24B
| $91.7K | ﹤0.01% |
96,800
-14,900
| -13% | -$14.1K |
|
2175
Playtika
PLTK
$1.42B
| $91.1K | ﹤0.01% |
+11,500
| New | +$91.1K |
|